Carolina Muñoz-Novas

COVID‐19 in patients with hematological malignancies: A retrospective case series

J. Churruca, P. Ryan, J. Hernández‐Rivas, 2020, International journal of laboratory hematology.

Blood transfusion activity in a general hospital during the COVID‐19 pandemic

J. Hernández‐Rivas, I. González-Gascón Y Marín, J. Churruca-Sarasqueta, 2020, Vox sanguinis.

Hypermetabolic abdominal and cervical lymph nodes mimicking Hodgkin lymphoma relapse on FDG PET/CT after adenovirus-vectored COVID-19 vaccine

J. Churruca, J. Hernández‐Rivas, J. C. Alonso-Farto, 2021, Human vaccines & immunotherapeutics.

Evaluation of the outcomes of newly diagnosed patients with high-risk myelodysplastic syndrome according to the initial therapeutical strategies chosen in usual clinical practice

M. Tormo, S. Brunet, J. Bargay, 2022, Leukemia & lymphoma.

From Biomarkers to Models in the Changing Landscape of Chronic Lymphocytic Leukemia: Evolve or Become Extinct

M. Hernández-Sánchez, J. Hernández‐Rivas, A. Rodríguez-Vicente, 2021, Cancers.

Prognosis Assessment of Early-Stage Chronic Lymphocytic Leukemia: Are We Ready to Predict Clinical Evolution Without a Crystal Ball?

F. Bosch, B. Espinet, M. Hernández-Sánchez, 2020, Clinical lymphoma, myeloma & leukemia.

The International Prognostic Index for Patients with Chronic Lymphocytic Leukemia Has the Higher Value in Predicting Overall Outcome Compared with the Barcelona-Brno Biomarkers Only Prognostic Model and the MD Anderson Cancer Center Prognostic Index

J. Hernández-Rivas, M. Hernández-Sánchez, A. Rodríguez-Vicente, 2018, BioMed research international.